LECT2 and metabolic dysfunction-associated steatotic liver disease: Previous study showed that LECT2 expression is significantly elevated in nonalcoholic fatty liver disease, and LECT2 induces the development and progression of Nonalcoholic fatty liver disease through the STAT-1 signal pathway (Wang et al., 2021).